There may be some very good reasons to do that. Lipitor, which Dr. Chaudhry views as probably the number-one selling drug in the world with millions of people taking the statin in an effort to control so-called bad LDL cholesterol, carries some nasty side effects.
Atorvastatin type 2 diabetes is one, when otherwise healthy Americans with a manageable weight suddenly find their blood sugars going off scale. Such was the case with plaintiff Margaret Clark, who launched a Lipitor diabetes lawsuit this past April following a diagnosis for type 2 diabetes. At a healthy weight, according to most North American standards, Clark alleges that it was the Lipitor she was prescribed 10 years prior, in 2002, which served as the conduit for her newfound health concern.
Dr. Chaudhry, indeed, includes type 2 diabetes as a side effect of statins including Lipitor. Other side effects include liver problems, kidney problems, muscle and joint pain, and memory loss, amongst other adverse reactions. ABC News with Diane Sawyer devoted a segment on the tendency for Lipitor in some patients to trigger forgetfulness and memory lapses akin to Alzheimer’s disease. The Lipitor patient in the piece noted that within eight days of stopping Lipitor, her memory returned just as sharp as before.
“These drugs work by interfering with the synthesis of production of cholesterol by the liver,” Dr. Chaudhry says in a video statement, “and when [statins] do that they do it through a mechanism which interferes with the production of some essential proteins that we need.” It is because of this interference in the production of these proteins that Lipitor patients and other consumers of statin drugs develop side effects.
Various studies have attempted to quantify the risk factors for side effects such as kidney or liver problems, and joint and muscle pain, together with the potential for Type 2 diabetes - amongst other Lipitor side effects.
With a pointed focus on the kidney, an exhaustive Canadian study this past spring looked at the health records of no fewer than two million patients in the US, Canada and Britain, with an eye to determining whether patients on more robust doses of statins were at a higher risk of developing kidney problems.
READ MORE LIPITOR DIABETES LEGAL NEWS
The study was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), and published in the BMJ (British Medical Journal). Meanwhile, various Lipitor patients having sustained negative changes to their overall health as the result of their use of Lipitor are looking to Lipitor Diabetes Lawsuits MDL in an effort to pursue compensation and achieve some form of justice from a manufacturer making healthy revenues from worldwide sales of Lipitor.
“By the way,” Dr. Chaudhry chimes in, “[Lipitor) produces approximately $12 to $14 billion for Pfizer every year.” He adds there are many ways in which to lower cholesterol levels naturally. Many health experts advocate the same thing.
READER COMMENTS
Dave Lance
on
Over the past few years the following have progressively moved out of range - Triglycerides, Hemoglobin A1C, Glucose, Monocytes, Eosinophils and Alkaline Phosphatase. I am not a physician and I do not know if these are all related, but from what I have read most of these are related to liver function and the onset of diabetes.
I have been taking Lipitor regularly for approximately 18 years and I am writing this note since I have recently read a few articles about concerns over long term use. I am meeting with my primary care physician this coming week and I will discuss this concern with him, but I plan to suggest stopping Lipitor for a month or so to see if the indicators change significantly.
I am looking for any advice on this matter and hopefully my comments will be helpful to someone.
Hanu
on